Clinical trial
Endovascular Treatment for Symptomatic Non-acute Carotid Occlusion - A Multicenter, Prospective, Blind Endpoint, Pilot, Randomized Controlled Trial
NCT07803419 is registered in ClinicalTrials.gov with Dapeng Mo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endovascular Treatment for Symptomatic Non-acute Carotid Occlusion - A Multicenter, Prospective, Blind Endpoint, Pilot, Randomized Controlled Trial
- Lead sponsor
- Dapeng Mo
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 1, 2028
- Enrollment
- 180 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment, non-acute carotid artery occlusion